These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33749584)

  • 1. Regional citrate anticoagulation protocol suitable for intermittent hemodialysis and post-dilution hemodiafiltration.
    Goet E; Wentz B; Frank RD
    Clin Nephrol; 2021 Aug; 96(2):90-95. PubMed ID: 33749584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of acid-base control, electrolyte balance, and filter patency of a Prismaflex-based regional citrate anticoagulation protocol for pre-dilution continuous veno-venous hemodiafiltration.
    Khadzhynov D; Slowinski T; Lieker I; Neumayer HH; Peters H
    Clin Nephrol; 2014 May; 81(5):320-30. PubMed ID: 24780554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional citrate anticoagulation is safe in intermittent high-flux haemodialysis treatment of children and adolescents with an increased risk of bleeding.
    Kreuzer M; Bonzel KE; Büscher R; Offner G; Ehrich JH; Pape L
    Nephrol Dial Transplant; 2010 Oct; 25(10):3337-42. PubMed ID: 20466660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A noninferiority trial comparing a heparin-grafted membrane plus citrate-containing dialysate versus regional citrate anticoagulation: results of the CiTED study.
    Meijers B; Metalidis C; Vanhove T; Poesen R; Kuypers D; Evenepoel P
    Nephrol Dial Transplant; 2017 Apr; 32(4):707-714. PubMed ID: 28407129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of regional citrate anticoagulation in pediatric high-flux dialysis: activated coagulation time versus post-filter ionized calcium.
    Kreuzer M; Ahlenstiel T; Kanzelmeyer N; Ehrich JH; Pape L
    Pediatr Nephrol; 2010 Jul; 25(7):1305-10. PubMed ID: 20221775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin-coated polyacrylonitrile membrane versus regional citrate anticoagulation: a prospective randomized study of 2 anticoagulation strategies in patients at risk of bleeding.
    Evenepoel P; Dejagere T; Verhamme P; Claes K; Kuypers D; Bammens B; Vanrenterghem Y
    Am J Kidney Dis; 2007 May; 49(5):642-9. PubMed ID: 17472846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A regional citrate anticoagulation protocol for pre-dilutional CVVHDf: the 'Modified Alabama Protocol'.
    Davies H; Morgan D; Leslie G
    Aust Crit Care; 2008 Aug; 21(3):154-65. PubMed ID: 18635373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving the delivery of continuous renal replacement therapy using regional citrate anticoagulation.
    Swartz R; Pasko D; O'Toole J; Starmann B
    Clin Nephrol; 2004 Feb; 61(2):134-43. PubMed ID: 14989634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional citrate anticoagulation "non-shock" protocol with pre-calculated flow settings for patients with at least 6 L/hour liver citrate clearance.
    Yessayan L; Sohaney R; Puri V; Wagner B; Riddle A; Dickinson S; Napolitano L; Heung M; Humes D; Szamosfalvi B
    BMC Nephrol; 2021 Jul; 22(1):244. PubMed ID: 34215201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automated regional citrate anticoagulation: technological barriers and possible solutions.
    Szamosfalvi B; Frinak S; Yee J
    Blood Purif; 2010; 29(2):204-9. PubMed ID: 20093828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between regional citrate anticoagulation and heparin for intermittent hemodialysis in ICU patients: a propensity score-matched cohort study.
    Leroy C; Pereira B; Soum E; Bachelier C; Coupez E; Calvet L; Bachoumas K; Dupuis C; Souweine B; Lautrette A
    Ann Intensive Care; 2021 Jan; 11(1):13. PubMed ID: 33481169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simplified protocol for individualized regional citrate anticoagulation for hemodialysis: A single-center, randomized clinical study.
    Luo L; Fan M; Chen Q; Cheng J
    Medicine (Baltimore); 2021 Feb; 100(8):e24639. PubMed ID: 33663073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Avoidance of systemic anticoagulation during intermittent haemodialysis with heparin-grafted polyacrilonitrile membrane and citrate-enriched dialysate: a retrospective cohort study.
    François K; Wissing KM; Jacobs R; Boone D; Jacobs K; Tielemans C
    BMC Nephrol; 2014 Jul; 15():104. PubMed ID: 24993584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified regional citrate anticoagulation is optimal for hemodialysis in patients at high risk of bleeding: a prospective randomized study of three anticoagulation strategies.
    Lin T; Song L; Huang R; Huang Y; Tang S; Lin Q; Zhang Y; Wu X; Liang H; Wu Y; Chen Y; Liang H; Ma J; Feng Z; Li Z; Xu L; Fu X; Ye Z; Liu S; Liang X
    BMC Nephrol; 2019 Dec; 20(1):472. PubMed ID: 31856749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of regional citrate anticoagulation in patients at high risk of bleeding during intermittent hemodialysis: a prospective multicenter randomized controlled trial.
    Tang X; Chen D; Zhang L; Fu P; Chen Y; Xiao Z; Xiao X; Peng W; Cheng L; Zhang Y; Li H; Li K; Gou B; Wu X; Yu Q; Jian L; Zhu Z; Wen Y; Liu C; Xue H; Zhang H; He X; Yan B; Zhong L; Huang B; Mao M
    J Zhejiang Univ Sci B; 2022 Nov; 23(11):931-942. PubMed ID: 36379612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous venovenous hemodiafiltration (CVVHDF) with citrate anticoagulation in the treatment of a patient with acute renal failure, hypercalcemia, and thrombocytopenia.
    Srámek V; Novák I; Matĕjovic M; Rokyta R; Nalos M; Hora P; Pittrová H
    Intensive Care Med; 1998 Mar; 24(3):262-4. PubMed ID: 9565811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of a Protocol for Continuous Hemodiafiltration with Regional Citrate Anticoagulation with Omni®.
    Whiting L; Bianchi NA; Alouazen K; Joannes-Boyau O; Chiche JD; Schneider A
    Blood Purif; 2022; 51(12):1039-1047. PubMed ID: 35636389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Citrate anticoagulation for single-needle hemodialysis: safety and efficacy.
    Buturović-Ponikvar J; Gubensek J; Ponikvar R
    Ther Apher Dial; 2005 Jun; 9(3):237-40. PubMed ID: 15966997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simple citrate anticoagulation protocol for low flux haemodialysis.
    Lim EK; Seow YT; Chen SE; Yang G; Liaw ME; Isaac S
    BMC Nephrol; 2018 Jan; 19(1):16. PubMed ID: 29351783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional citrate anticoagulation for high volume continuous venovenous hemodialysis in surgical patients with high bleeding risk.
    Kalb R; Kram R; Morgera S; Slowinski T; Kindgen-Milles D
    Ther Apher Dial; 2013 Apr; 17(2):202-12. PubMed ID: 23551677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.